Ani Pharmaceuticals (ANIP) EBT (2011 - 2026)
Ani Pharmaceuticals (ANIP) posted EBT of $40.2 million for Q1 2026, up 27.77% sequentially from $31.5 million in Q4 2025, and up 101.24% YoY from $20.0 million in Q1 2025.
Ani Pharmaceuticals (ANIP) EBT (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported EBT for 16 years, with the latest figure at $40.2 million in Q1 2026.
- Quarterly EBT rose 101.24% year-over-year to $40.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $116.0 million (up 520.99% YoY) and the FY2025 annual result came in at $95.8 million, up 531.26% from the prior year.
- EBT rose to $40.2 million in Q1 2026 per ANIP's latest filing, from $31.5 million in the prior quarter.
- Over five years, EBT peaked at $40.2 million in Q1 2026 and troughed at -$31.5 million in Q3 2024.
- A 5-year average of $4.2 million and a median of $2.2 million in 2023 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2024: EBT slumped 34178.95% in 2022, then soared 1070.21% in 2024.
- Over 5 years, EBT stood at -$5.8 million in 2022, then surged by 116.43% to $947000.0 in 2023, then tumbled by 1553.22% to -$13.8 million in 2024, then jumped by 328.74% to $31.5 million in 2025, then climbed by 27.77% to $40.2 million in 2026.
- According to Business Quant data, EBT over the past three periods registered $40.2 million, $31.5 million, and $33.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 37.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.10 Mn |
| Mar 31, 2026 | 40.22 Mn |
| Dec 31, 2025 | 31.48 Mn |
| Sep 30, 2025 | 33.80 Mn |
| Jun 30, 2025 | 10.53 Mn |
| Mar 31, 2025 | 19.99 Mn |
| Dec 31, 2024 | -13.76 Mn |
| Sep 30, 2024 | -31.50 Mn |
| Jun 30, 2024 | -2.29 Mn |
| Mar 31, 2024 | 25.34 Mn |
| Dec 31, 2023 | 947,000.00 |
| Sep 30, 2023 | 11.51 Mn |
| Jun 30, 2023 | 5.25 Mn |
| Mar 31, 2023 | 2.17 Mn |
| Dec 31, 2022 | -5.77 Mn |
| Sep 30, 2022 | -12.22 Mn |
| Jun 30, 2022 | -18.82 Mn |
| Mar 31, 2022 | -25.90 Mn |
| Dec 31, 2021 | -30.85 Mn |
| Sep 30, 2021 | -7.10 Mn |